BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 20055911)

  • 21. [Multiple sebaceous tumors with colon cancer--Muir-Torre syndrome].
    Vajda A; Scharrer K; Baló-Banga JM
    Orv Hetil; 2003 May; 144(20):985-9. PubMed ID: 12830729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Muir-Torre syndrome and Turcot syndrome].
    Velter C; Caussade P; Fricker JP; Cribier B
    Ann Dermatol Venereol; 2017; 144(8-9):525-529. PubMed ID: 28256262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Muir-Torre syndrome.
    Johnson PJ; Heckler F
    Ann Plast Surg; 1998 Jun; 40(6):676-7. PubMed ID: 9641292
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dermatology clinics: what's new in dermatopathology: news in nonmelanocytic neoplasia.
    Sidhu HK; Patel RV; Goldenberg G
    Dermatol Clin; 2012 Oct; 30(4):623-41, vi. PubMed ID: 23021050
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Muir-Torre Syndrome in a Middle-Aged Chinese Patient with Sebaceous Carcinoma of the Eyelid.
    Wong CY; Tang RK; Lam RF; Io IY; Yuen CY; Ho JW; Tse RK
    Semin Ophthalmol; 2015; 30(5-6):420-2. PubMed ID: 24117411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metastatic Prostatic Adenocarcinoma in Patient With Muir-Torre Syndrome Misdiagnosed as Metastatic Sebaceous Carcinoma: Case Report and Systematic Literature Review.
    Cattelan L; Abi-Rafeh J; Brimo F; Kazan R; Redpath M; Chergui M
    Am J Dermatopathol; 2020 Sep; 42(9):700-705. PubMed ID: 32568842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fordyce granules and hyperplastic mucosal sebaceous glands as distinctive stigmata in Muir-Torre syndrome patients: characterization with reflectance confocal microscopy.
    Ponti G; Meschieri A; Pollio A; Ruini C; Manfredini M; Longo C; Mandel VD; Ciardo S; Tomasi A; Giannetti L; Pellacani G
    J Oral Pathol Med; 2015 Aug; 44(7):552-7. PubMed ID: 25213213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ocular Adnexal Adenomatoid Sebaceous Gland Hyperplasia: A Clinical and Immunopathologic Analysis in Relation to the Muir-Torre Syndrome.
    Jakobiec FA; Cortes Barrantes P; Milman T; Lee NG; Fay A
    Ophthalmic Plast Reconstr Surg; 2020; 36(1):e6-e12. PubMed ID: 31593035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple benign adnexal tumours: Anything but benign.
    McCarthy RL; Thomas CL; Isaacs F
    Australas J Dermatol; 2019 Aug; 60(3):234-236. PubMed ID: 30671930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sebaceous carcinoma of the eyelid and Muir-Torre syndrome.
    Gauthier AS; Campolmi N; Tumahai P; Kantelip B; Delbosc B
    JAMA Ophthalmol; 2014 Aug; 132(8):1025-8. PubMed ID: 24969841
    [No Abstract]   [Full Text] [Related]  

  • 31. Cutaneous sebaceous tumours and Lynch syndrome: long-term follow-up of 60 patients.
    Marcoval J; Talavera-Belmonte A; Fornons-Servent R; Bauer-Alonso A; Penín RM; Servitje O
    Clin Exp Dermatol; 2019 Jul; 44(5):506-511. PubMed ID: 30430625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sebaceous neoplasms in Muir-Torre syndrome.
    Misago N; Narisawa Y
    Am J Dermatopathol; 2000 Apr; 22(2):155-61. PubMed ID: 10770437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A clinical scoring system to identify patients with sebaceous neoplasms at risk for the Muir-Torre variant of Lynch syndrome.
    Roberts ME; Riegert-Johnson DL; Thomas BC; Rumilla KM; Thomas CS; Heckman MG; Purcell JU; Hanson NB; Leppig KA; Lim J; Cappel MA
    Genet Med; 2014 Sep; 16(9):711-6. PubMed ID: 24603434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Muir-Torre syndrome associated with Waldenstrom's macroglobulinemia].
    Velter C; Bourlond F; Wettle C; Lioure B; Lipsker D; Maugard C; Cribier B
    Ann Dermatol Venereol; 2016 Dec; 143(12):825-830. PubMed ID: 27771121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Muir-Torre syndrome: a case report and review of the literature.
    Okan G; Vural P; Ince Ü; Yazar A; Uras C; Saruç M
    Turk J Gastroenterol; 2012 Aug; 23(4):394-8. PubMed ID: 22965514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Muir-Torre syndrome: role of the dermatopathologist in diagnosis.
    Curry ML; Eng W; Lund K; Paek D; Cockerell CJ
    Am J Dermatopathol; 2004 Jun; 26(3):217-21. PubMed ID: 15166510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expanding the Spectrum of Skin Neoplasms in Muir-Torre Syndrome: Beyond Sebaceous Tumours.
    Díaz-Calvillo P; Gómez-Jiménez C; Sabushimike D; González-Sarmiento R; Roncero-Riesco M; Santos-Briz Á
    Am J Dermatopathol; 2024 Mar; 46(3):189-191. PubMed ID: 38354387
    [No Abstract]   [Full Text] [Related]  

  • 38. Update on the pathology, genetics and somatic landscape of sebaceous tumours.
    Ferreira I; Wiedemeyer K; Demetter P; Adams DJ; Arends MJ; Brenn T
    Histopathology; 2020 Apr; 76(5):640-649. PubMed ID: 31821583
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Muir-Torre syndrome in a black patient with AIDS: histopathology and molecular genetic studies.
    Warschaw KE; Eble JN; Hood AF; Wolverton SE; Halling KC
    J Cutan Pathol; 1997 Sep; 24(8):511-8. PubMed ID: 9331898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extraocular well-differentiated sebaceous tumors with overlying cutaneous horns: four tumors in three patients.
    Jhuang JY; Liao SL; Tsai JH; Chang HC; Kuo KT; Liau JY
    J Cutan Pathol; 2014 Aug; 41(8):650-6. PubMed ID: 24548110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.